A previous study alsodemonstrated the unique features of cases carrying IGLL5 mutations, including prominence in lower-risk mutated CLL, off-target activation-induced cytidine deaminase (AID) activity, and gene mutations previously undescribed (21). Here, IGLL5 is linked to B-cell chronic lymphocytic leukemia.